tirzepatide approved for osa The FDA has expanded the approval of Eli Lilly's obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea people with obesity — the first medication for the Lilly Rises on FDA Approval

Levity.com takes safety seriously and offers a platform you can trust, especially when it comes to important wellness medications

Handle according to established laboratory safety procedures

The Parenteral route of administration accounted for 67.45% of the market in 2025, owing to the established use of injectable GLP-1 agonists, superior bioavailability, extensive clinical validation, and widespread physician familiarity

Looking Ahead While the data are promising, the existing body of evidence is still limited by small sample sizes and observational study designs

By this point, appetite suppression is well-established

Our guide on how much bacteriostatic water to mix with 10 mg tirzepatide walks through the process step by step